Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 63629-9172

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 63629-9172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636299172)

Metoprolol Succinate Extended-Release Tablets, USP 100 mg film-coated, extended-release tablets, packaged by Bryant Ranch Prepack. The label includes dosage information indicating each tablet contains 95 mg metoprolol succinate, equivalent to 100 mg metoprolol tartrate. The package contains 1000 tablets with NDC 63629-9172-1, featuring storage instructions and a caution to verify product dispensed.*

FDA Label Image

Metoprolol-structure (Metoprolol Structure)

Chemical structure of Metoprolol Succinate, showing the molecular arrangement of the active ingredient including the metoprolol moiety and succinate component.*

FDA Label Image

Metoprolol-table1 (Metoprolol Table1)

A forest plot displaying results for subgroups in the MERIT-HE study comparing TOPROL-XL versus placebo. The plot illustrates relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure across various subgroups including demographics, clinical characteristics, and heart rate levels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.